Jacques‐Olivier Bay

Bevacizumab plus interferon alfa-2a for treatment of metastatic renal cell carcinoma: a randomised, double-blind phase III trial

Bernard Escudier, P. Koralewski, Alain Ravaud et al. · The Lancet · 2007 · 2.2K citations

Urology, Surgical Oncology, Oncology +4

Docetaxel and gemcitabine combination in 133 advanced soft‐tissue sarcomas: A retrospective analysis

Jacques‐Olivier Bay, Isabelle Ray‐Coquard, Jérôme Fayette et al. · International Journal of Cancer · 2006 · 183 citations

Allogeneic haematopoietic stem cell transplantation for myelofibrosis: a report of the Société Française de Greffe de Moelle et de Thérapie Cellulaire (SFGM‐TC)

Marie Robin, Reza Tabrizi, Mohamad Mohty et al. · British Journal of Haematology · 2010 · 111 citations · Full text

Immunology, Transplantation Medicine, Pathology +17

Randomized study of 2 reduced‐intensity conditioning strategies for human leukocyte antigen‐matched, related allogeneic peripheral blood stem cell transplantation

Didier Blaise, Reza Tabrizi, Jean‐Marie Boher et al. · Cancer · 2012 · 79 citations

Unrelated Cord Blood Transplantation for Patients with Primary or Secondary Myelofibrosis

Marie Robin, Federica Giannotti, Éric Deconinck et al. · Biology of Blood and Marrow Transplantation · 2014 · 59 citations · Full text